KPE-00001113

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameKPE-00001113

Drug Alias NameKPE-00001113

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKemin

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKemin

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A